| Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer (NCT05041101) | M.D. Anderson Cancer Center | 2021-12-21 |
| Omacetaxine and Venetoclax for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Harboring Mutant RUNX1 (NCT04874194) | M.D. Anderson Cancer Center | 2021-12-17 |
| Barriers and Facilitators in Access to OT/PT in Pediatric Cancer Survivors (NCT05305950) | M.D. Anderson Cancer Center | 2021-12-17 |
| Hypofractionated Radiation Therapy for Merkel Cell Carcinoma (NCT05100095) | M.D. Anderson Cancer Center | 2021-12-14 |
| Fecal Microbial Transplants for the Treatment of Pancreatic Cancer (NCT04975217) | M.D. Anderson Cancer Center | 2021-12-14 |
| TAME: A Pilot Study of Weekly Paclitaxel, Bevacizumab, and Tumor Associated Macrophage Targeted Therapy (Zoledronic Acid) in Women With Recurrent, Platinum-resistant, Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (NCT05053750) | M.D. Anderson Cancer Center | 2021-12-14 |
| Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer (NCT05042687) | M.D. Anderson Cancer Center | 2021-12-13 |
| Parenting Support Intervention for Families Coping With Metastatic or Locally Recurrent Solid Tumor Diagnosis (NCT05059678) | M.D. Anderson Cancer Center | 2021-11-30 |
| Venetoclax and Eprenetapopt for the Treatment of Relapsed of Refractory Mantle Cell Lymphoma (NCT04990778) | M.D. Anderson Cancer Center | 2021-11-30 |
| Positive Activities for Asian American Cancer Patients and Caregivers (NCT05203614) | M.D. Anderson Cancer Center | 2021-11-30 |
| Comparing the Performance of Automated Breast Ultrasonography to Hand-Held Whole Breast Ultrasonography in Breast Cancer Treatment Response Assessment (NCT05005936) | M.D. Anderson Cancer Center | 2021-11-29 |
| A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC) (NCT05035836) | M.D. Anderson Cancer Center | 2021-11-16 |
| Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors (NCT05075993) | M.D. Anderson Cancer Center | 2021-11-12 |
| Pembrolizumab and Lenvatinib for the Treatment of Serous Ovarian Cancer Patients (NCT05114421) | M.D. Anderson Cancer Center | 2021-11-09 |
| Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid Cancer (NCT04171622) | M.D. Anderson Cancer Center | 2021-11-04 |
| Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA) (NCT05027633) | M.D. Anderson Cancer Center | 2021-11-02 |
| Vorinostat and Combination Chemotherapy Before Donor Stem Cell Transplantation for the Treatment of Relapsed Aggressive B-cell or T-cell Non-Hodgkin Lymphoma (NCT04220008) | M.D. Anderson Cancer Center | 2021-10-29 |
| Decitabine Alone or in Combination With Venetoclax, Gilteritinib, Enasidenib, or Ivosidenib as Maintenance Therapy for the Treatment of Acute Myeloid Leukemia in Remission (NCT05010772) | M.D. Anderson Cancer Center | 2021-10-25 |
| Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS (NCT04708054) | M.D. Anderson Cancer Center | 2021-10-21 |
| ASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic Phase (NCT05007873) | M.D. Anderson Cancer Center | 2021-10-21 |
| A Behavioral Activation Prenatal and Postpartum Intervention for Depressed Pregnant Smokers (NCT05044546) | M.D. Anderson Cancer Center | 2021-10-19 |
| ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma (NCT05025800) | M.D. Anderson Cancer Center | 2021-10-13 |
| A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder (NCT05137262) | M.D. Anderson Cancer Center | 2021-10-13 |
| DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease (NCT05036109) | M.D. Anderson Cancer Center | 2021-10-12 |
| Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients (NCT04712539) | M.D. Anderson Cancer Center | 2021-10-11 |
| Interdisciplinary Interventions to Address Pain Management Among Head and Neck Cancer Patients (NCT05077072) | M.D. Anderson Cancer Center | 2021-10-08 |
| Itacitinib for the Treatment of Bronchiolitis Obliterans Syndrome After Donor Hematopoietic Cell Transplant (NCT04239989) | M.D. Anderson Cancer Center | 2021-10-08 |
| Impact Of Muscle Vibration On Gait Control (NCT05061238) | M.D. Anderson Cancer Center | 2021-10-04 |
| EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Cancer (NCT05715216) | M.D. Anderson Cancer Center | 2021-10-01 |
| Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen (NCT05056857) | M.D. Anderson Cancer Center | 2021-10-01 |
| A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma (NCT05036681) | M.D. Anderson Cancer Center | 2021-09-30 |
| AL101 Before Surgery for the Treatment of Notch Activated Adenoid Cystic Cancer (NCT04973683) | M.D. Anderson Cancer Center | 2021-09-30 |
| IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors (NCT05039801) | M.D. Anderson Cancer Center | 2021-09-30 |
| Venetoclax in Combination With Decitabine and Cedazuridine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (NCT04975919) | M.D. Anderson Cancer Center | 2021-09-29 |
| Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer (NCT04940286) | M.D. Anderson Cancer Center | 2021-09-28 |
| Tegavivint for the Treatment of Relapsed or Refractory Leukemia (NCT04874480) | M.D. Anderson Cancer Center | 2021-09-27 |
| Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma (NCT04940299) | M.D. Anderson Cancer Center | 2021-09-23 |
| ARID1A and/or KDM6A Mutation and CXCL13 Expression (NCT04953104) | M.D. Anderson Cancer Center | 2021-09-21 |
| Nivolumab for the Treatment of Metastatic or Unresectable Solid Tumors With ARID1A Mutation and CXCL13 Expression (NCT04957615) | M.D. Anderson Cancer Center | 2021-09-21 |
| Comprehensive Evaluation of Tumor Oxygenation, Metabolism and Blood Supply of High Grade Glioma and Cervical Cancers Using Dynamic FAZA PET and Multiparametric MR (NCT05047913) | M.D. Anderson Cancer Center | 2021-09-20 |
| Gabapentin for the Reduction of Opiate Use Following Pulmonary Resection (GROUP Trial) (NCT05100160) | M.D. Anderson Cancer Center | 2021-09-15 |
| Magnetic Particle-ICG Lymph Node Mapping in Colorectal Cancer (NCT05092750) | M.D. Anderson Cancer Center | 2021-09-15 |
| Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma (NCT05042934) | M.D. Anderson Cancer Center | 2021-09-15 |
| PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN (NCT04983901) | M.D. Anderson Cancer Center | 2021-09-14 |
| Hypofractionated Radiation Therapy and Bintrafusp Alfa for the Treatment of Advanced Intrahepatic Cholangiocarcinoma (NCT04708067) | M.D. Anderson Cancer Center | 2021-08-31 |
| Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer (NCT04985565) | M.D. Anderson Cancer Center | 2021-08-27 |
| Sintilimab in Cancer of Unknown Primary (NCT05024968) | M.D. Anderson Cancer Center | 2021-08-26 |
| Association Between Gut Microbiome and Dietary Determinants and Vaccine Response (NCT05239403) | M.D. Anderson Cancer Center | 2021-08-24 |
| Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study (NCT05026736) | M.D. Anderson Cancer Center | 2021-08-23 |
| Fostamatinib for the Treatment of Lower-risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia Who Have Failed Therapy With Hypomethylating Agents (NCT05030675) | M.D. Anderson Cancer Center | 2021-08-13 |
| Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy (NCT05083338) | M.D. Anderson Cancer Center | 2021-08-10 |
| Novel Synthetic T2W MR Imaging and Spin Parameter Mapping Techniques for Screening Prostate Cancer (NCT05055843) | M.D. Anderson Cancer Center | 2021-08-10 |
| Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix (NCT05046080) | M.D. Anderson Cancer Center | 2021-08-06 |
| Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer (NCT04947254) | M.D. Anderson Cancer Center | 2021-08-05 |
| An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate Cancer (NCT04978675) | M.D. Anderson Cancer Center | 2021-08-04 |
| Promoting HPV Vaccination Among Young Adults in Texas (NCT05057312) | M.D. Anderson Cancer Center | 2021-07-26 |
| Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study (NCT04754412) | M.D. Anderson Cancer Center | 2021-07-23 |
| Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial (NCT04789681) | M.D. Anderson Cancer Center | 2021-07-20 |
| Evaluating Shared Decision-Making for Lung Cancer Screening Among Chinese Populations in the United States (NCT05024955) | M.D. Anderson Cancer Center | 2021-07-20 |
| Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer (NCT04754425) | M.D. Anderson Cancer Center | 2021-07-15 |
| Sintilimab for the Treatment of Locally Advanced, Metastatic, Recurrent, or Unresectable Undifferentiated Pleomorphic Sarcoma, SiARa Cancer Study (NCT05017103) | M.D. Anderson Cancer Center | 2021-07-13 |
| ASTX727, Venetoclax, and Gilteritinib for the Treatment of Newly Diagnosed, Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome (NCT05010122) | M.D. Anderson Cancer Center | 2021-07-08 |
| Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy (NCT04892953) | M.D. Anderson Cancer Center | 2021-07-07 |
| Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia (NCT04734990) | M.D. Anderson Cancer Center | 2021-07-07 |
| Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized Chemoradiation (NCT05010109) | M.D. Anderson Cancer Center | 2021-07-05 |
| Feasibility of Digital Thermal Monitoring to Assess Endothelium-Dependent Vasodilation in Patients Undergoing Hematopoietic Cell Transplantation (HCT) (NCT05029752) | M.D. Anderson Cancer Center | 2021-06-30 |
| Anti-Leukemia Immune Responses After Irradiation of Extramedullary Tumors (NCT05035706) | M.D. Anderson Cancer Center | 2021-06-30 |
| Bintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung Cancer (NCT04971187) | M.D. Anderson Cancer Center | 2021-06-30 |
| Acalabrutinib and Rituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma (NCT04765111) | M.D. Anderson Cancer Center | 2021-06-30 |
| Patient-Informed Educational Intervention for the Improvement of Cervical Cancer Literacy (NCT05093712) | M.D. Anderson Cancer Center | 2021-06-28 |
| Lifestyle Intervention for the Reduction of Breast Cancer Risk in Normal Weight Women (NCT04267796) | M.D. Anderson Cancer Center | 2021-06-25 |
| Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer (NCT04675710) | M.D. Anderson Cancer Center | 2021-06-24 |
| Frequency of Cachexia in Ambulatory Cancer Patients and Psychological Burden in Patients and Their Primary Caregivers (NCT04090619) | M.D. Anderson Cancer Center | 2021-06-22 |
| Use of Google Translate to Enhance Patient Pain and Nausea Assessment and Satisfaction After General Anesthesia (NCT05060328) | M.D. Anderson Cancer Center | 2021-06-22 |
| Multicomponent Physical Activity Intervention for the Reduction of Psychosocial Distress in Cancer Patients (NCT05056831) | M.D. Anderson Cancer Center | 2021-06-21 |
| Geriatric Care Survivorship Intervention for Improving the Overall Health of Older Adults With Stage I-III Breast Cancer Who Have Completed Curative Treatment (NCT05928325) | M.D. Anderson Cancer Center | 2021-06-17 |
| Poziotinib and Ramucirumab for the Treatment of EGFR Exon 20 Mutant Stage IV Non-small Cell Lung Cancer (NCT05045404) | M.D. Anderson Cancer Center | 2021-06-16 |
| Uproleselan, Cladribine, and Low Dose Cytarabine for the Treatment of Patients With Treated Secondary Acute Myeloid Leukemia (NCT04848974) | M.D. Anderson Cancer Center | 2021-06-11 |
| Patient Perceptions of the Relational Empathy of Healthcare Practitioners From the Department of Emergency Medicine During the COVID-19 Pandemic (NCT05102656) | M.D. Anderson Cancer Center | 2021-06-02 |
| Customized 3D Printed Oral Stents During Head and Neck Radiotherapy (NCT04870762) | M.D. Anderson Cancer Center | 2021-05-26 |
| Decitabine/Cedazuridine and Venetoclax in Combination With Ivosidenib or Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (NCT04774393) | M.D. Anderson Cancer Center | 2021-05-24 |
| ProvoxLife Adoption Trends for Heat-Moisture Exchanger (NCT05036330) | M.D. Anderson Cancer Center | 2021-05-21 |
| Liposomal Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin for the Treatment of Relapsed Refractory Pediatric Patients With Acute Myeloid Leukemia (NCT04915612) | M.D. Anderson Cancer Center | 2021-05-21 |
| Mobile-Health Delivery of Lifestyle Interventions for Women With Breast Cancer (NCT05132296) | M.D. Anderson Cancer Center | 2021-05-21 |
| Telotristat Ethyl for the Treatment of Carcinoid Heart Disease in Patients With Metastatic Neuroendocrine Tumor (NCT04810091) | M.D. Anderson Cancer Center | 2021-05-18 |
| Positive Activities Intervention to Improve Quality of Life in Collectivist Culture Cancer Patients and Their Caregivers (NCT04810052) | M.D. Anderson Cancer Center | 2021-05-18 |
| Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events (NCT05038254) | M.D. Anderson Cancer Center | 2021-05-12 |
| PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapy (NCT04745949) | M.D. Anderson Cancer Center | 2021-05-10 |
| Bone Loss in Melanoma Survivors Receiving Immunotherapy (NCT04516122) | M.D. Anderson Cancer Center | 2021-05-10 |
| Assessment of Verbal Comprehension and Cognitive Processes in Patients Admitted to the Palliative and Supportive Care Unit (NCT05091632) | M.D. Anderson Cancer Center | 2021-05-04 |
| Treatment Decision Making in African American Women Diagnosed With Triple Negative Breast Cancer (NCT05071677) | M.D. Anderson Cancer Center | 2021-05-03 |
| Larotrectinib for the Treatment of NTRK Amplification Positive, Locally Advanced or Metastatic Solid Tumors (NCT04879121) | M.D. Anderson Cancer Center | 2021-04-30 |
| Distress Associated with Coronavirus Disease 2019 and Telehealth on Supportive Care Patients with Advanced Cancer (NCT05058339) | M.D. Anderson Cancer Center | 2021-04-27 |
| Glutamine PET Imaging Colorectal Cancer (NCT03275974) | M.D. Anderson Cancer Center | 2021-04-27 |
| Survey Assessment of Patient and Provider Impressions of Telemedicine in Radiation Oncology (NCT05496972) | M.D. Anderson Cancer Center | 2021-04-21 |
| Feasibility of Mobile-CT-Assisted Bronchoscopy for the Diagnosis of Lung Lesion (NCT04995172) | M.D. Anderson Cancer Center | 2021-04-19 |
| Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method (NCT05054413) | M.D. Anderson Cancer Center | 2021-04-15 |
| Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple Discharge (NCT05056844) | M.D. Anderson Cancer Center | 2021-04-15 |
| Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies (NCT04902040) | M.D. Anderson Cancer Center | 2021-04-14 |
| Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic Malignancies (NCT04888338) | M.D. Anderson Cancer Center | 2021-04-10 |